Compliance and Cumulative Interceptive Rate After Therapy of Peri-implantitis

Center of Implantology, Oral and Maxillofacial Surgery, Badajoz, Spain

Status: Completed

Conditions: Peri-Implantitis

Treatments: Other: Assess compliance rate and demographics

Study type: Observational

Funder types: Other

Identifiers

NCT05772078

20230208

Details and patient eligibility

About

Peri-implantitis is a plaque-mediated inflammatory condition featured by progressive bone loss. This entity jeopardizes the longevity of dental implants, thus impacting negatively on the quality of life of patients. Moreover, peri-implantitis is suggested to lead to an increased systemic status of inflammation. This may rise the susceptibility to experience life-threating conditions. Therefore, peri-implant infections must be promptly diagnosed and eliminated.

Aiming at resolving the inflammation, several options are advised to remove the infection. Accordingly, implant removal or therapeutic manoeuvres to stablish a healthy ecosystem in the peri-implant environment have been suggested. While the former proved being more predictable, the later demonstrated being more conservative. Indeed, implant removal is commonly associated with regenerative procedures of the alveolar bone deformity that often demand time and is more costly. Anyways, disease severity, implant expendability for biomechanical reasons or esthetic demand seem to be few of the leading aspects in the decision-making process on maintaining or extracting implant showing peri-implant lesions.

Supportive maintenance care (SPT) was shown to be key in preventing disease recurrence. Nonetheless, the compliance of these patients is often erratic. In fact, it is yet unknown the rate of compliance after therapy. Therefore, the goal of this study is to assess the rate and confounders for compliance.

Enrollment: 140 patients

Sex: All

Ages: 18 to 85 years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• Patients that underwent treatment of peri-implantitis
• >12 months of follow-up after therapy
• Patients managed in our center

Exclusion criteria

• Patients that were managed in other centers
• Patients that have incomplete records

Trial design

140 participants in 3 patient groups

Compliers

Description:

Attending to SPT every 4-6 months

Treatment:

Other: Assess compliance rate and demographics

Erratic compliers

Description:

Attending to SPT once a year or sporadically

Treatment:

Other: Assess compliance rate and demographics

Non compliers

Description:

Non-attenders to SPT

Treatment:

Other: Assess compliance rate and demographics